— The T cell therapy company heads to ASH 2024 next month to introduce its novel allogeneic protection and cytokine engineering strategies to support the development of potent and persistent off-the-shelf UNi-T cells — VANCOUVER, BC, Nov. 5, 2024 /PRNewswire/ — Notch Therapeutics, Inc.,…
